Zoetis (ZTS) Operating Income (QoQ) (2012 - 2026)

Zoetis (ZTS) Operating Income (QoQ) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.67 Bn 34.93 Bn 1.97 Bn
2 Zoetis 30.59 Bn 28.65 Bn 1.62 Bn
3 RedHill Biopharma 26.22 Bn 26.22 Bn -
4 United Therapeutics 23.80 Bn 21.65 Bn 648.10 Mn
5 Curaleaf Holdings 23.70 Bn 23.70 Bn 157.29 Mn
6 Viatris 18.69 Bn 16.89 Bn 1.16 Bn
7 Neurocrine Biosciences 16.86 Bn 15.54 Bn 800.70 Mn
8 Elanco Animal Health 11.99 Bn 11.57 Bn 785.00 Mn
9 Dr Reddys Laboratories 11.65 Bn 11.51 Bn -
10 Vireo Growth 10.64 Bn 10.52 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.95%
Dec 31, 2025 -12.76%
Sep 30, 2025 -5.68%
Jun 30, 2025 21.09%
Mar 31, 2025 5.24%
Dec 31, 2024 -16.20%
Sep 30, 2024 5.86%
Jun 30, 2024 9.31%
Mar 31, 2024 11.01%
Dec 31, 2023 -9.15%
Sep 30, 2023 -4.98%
Jun 30, 2023 15.99%
Mar 31, 2023 2.20%
Dec 31, 2022 -3.45%
Sep 30, 2022 -1.05%
Jun 30, 2022 -7.97%
Mar 31, 2022 28.97%
Dec 31, 2021 -15.42%
Sep 30, 2021 2.02%
Jun 30, 2021 672.31%